|
|
||||||||
The Journal of Immunology, Vol 153, Issue 10 4508-4519, Copyright © 1994 by American Association of Immunologists
ARTICLES |
RL Yauch and BS Kim
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611.
The intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV) into susceptible strains of mice results in a chronic, immune-mediated demyelinating disease that shares many features with human multiple sclerosis. As with human MS, T lymphocytes seem to be critically important for the pathogenesis of this virally induced, demyelinating disease. Therefore, determining the fine specificity of the T cell response may be essential for elucidating the mechanism(s) involved in demyelination. By using fusion proteins and synthetic peptides, we have initially identified a region within the amino acid residues 233 to 250 of the VP1 capsid protein of Theiler's virus that is recognized by T cells from either TMEV-immunized or TMEV-infected, demyelination-susceptible SJL/J mice. A T lymphocyte precursor frequency analysis indicates that a major TMEV-reactive T cell population in the periphery of virus-infected mice recognizes this VP1 region. The fine epitope specificity has been further determined to be within VP1(233-244) using additional synthetic peptides. VP1(233-244)- specific T cells seem to represent a significant population of TMEV- reactive T lymphocytes within the demyelinating lesions, because such T cells have been cloned from the spinal cords of infected mice. Interestingly, all TMEV-specific T cell clones derived from the demyelinating lesions, regardless of epitope specificity, produce IFN- gamma on stimulation and thus may play a critical role in the recruitment and activation of inflammatory cells leading to demyelination. Taken together, these data suggest that a T cell response against VP1(233-244) is involved in the pathogenesis of TMEV- induced demyelinating disease.
This article has been cited by other articles:
![]() |
Z. Liang, A. S. M. Kumar, M. S. Jones, N. J. Knowles, and H. L. Lipton Phylogenetic Analysis of the Species Theilovirus: Emerging Murine and Human Pathogens J. Virol., December 1, 2008; 82(23): 11545 - 11554. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Myoung, Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice J. Virol., June 1, 2008; 82(11): 5606 - 5617. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Jin, M. Mohindru, M. H. Kang, A. C. Fuller, B. Kang, D. Gallo, and B. S. Kim Differential Virus Replication, Cytokine Production, and Antigen-Presenting Function by Microglia from Susceptible and Resistant Mice Infected with Theiler's Virus J. Virol., November 1, 2007; 81(21): 11690 - 11702. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Fuller, B. Kang, H. K. Kang, H. Yahikozowa, M. C. Dal Canto, and B. S. Kim Gender Bias in Theiler's Virus-Induced Demyelinating Disease Correlates with the Level of Antiviral Immune Responses J. Immunol., September 15, 2005; 175(6): 3955 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Kang, M. A. Lyman, and B. S. Kim Differences in Avidity and Epitope Recognition of CD8+ T Cells Infiltrating the Central Nervous Systems of SJL/J Mice Infected with BeAn and DA Strains of Theiler's Murine Encephalomyelitis Virus J. Virol., November 20, 2002; 76(22): 11780 - 11784. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, M. K. Njenga, A. J. Johnson, K. D. Pavelko, C. S. David, L. R. Pease, and M. Rodriguez Transgenic Expression of Theiler's Murine Encephalomyelitis Virus Genes in H-2b Mice Inhibits Resistance to Virus-Induced Demyelination J. Virol., June 27, 2002; 76(15): 7799 - 7811. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Kang, M. A. Lyman, and B. S. Kim The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional J. Virol., June 5, 2002; 76(13): 6577 - 6585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Palma, R. L. Yauch, H.-K. Kang, H.-G. Lee, and B. S. Kim Preferential Induction of IL-10 in APC Correlates with a Switch from Th1 to Th2 Response Following Infection with a Low Pathogenic Variant of Theiler's Virus J. Immunol., April 15, 2002; 168(8): 4221 - 4230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lyman, H.-G. Lee, B. S. Kang, H.-K. Kang, and B. S. Kim Capsid-Specific Cytotoxic T Lymphocytes Recognize Three Distinct H-2Db-Restricted Regions of the BeAn Strain of Theiler's Virus and Exhibit Different Cytokine Profiles J. Virol., March 7, 2002; 76(7): 3125 - 3134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Kang, M. Mohindru, B.-S. Kang, S. H. Park, and B. S. Kim Clonal Expansion of Infiltrating T Cells in the Spinal Cords of SJL/J Mice Infected with Theiler's Virus J. Immunol., July 1, 2000; 165(1): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Kim, Y. Y. Bahk, H.-K. Kang, R. L. Yauch, J.-A. Kang, M.-J. Park, and N. M. Ponzio Diverse Fine Specificity and Receptor Repertoire of T Cells Reactive to the Major VP1 Epitope (VP1230-250) of Theiler's Virus: V{beta} Restriction Correlates with T Cell Recognition of the C-Terminal Residue J. Immunol., June 15, 1999; 162(12): 7049 - 7057. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Palma, R. L. Yauch, S. Lang, and B. S. Kim Potential Role of CD4+ T Cell-Mediated Apoptosis of Activated Astrocytes in Theiler's Virus-Induced Demyelination J. Immunol., June 1, 1999; 162(11): 6543 - 6551. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. McCright, I. Tsunoda, F. G. Whitby, and R. S. Fujinami Theiler's Viruses with Mutations in Loop I of VP1 Lead to Altered Tropism and Pathogenesis J. Virol., April 1, 1999; 73(4): 2814 - 2824. [Abstract] [Full Text] |
||||
![]() |
N. D. Tolley, I. Tsunoda, and R. S. Fujinami DNA Vaccination against Theiler's Murine Encephalomyelitis Virus Leads to Alterations in Demyelinating Disease J. Virol., February 1, 1999; 73(2): 993 - 1000. [Abstract] [Full Text] |
||||
![]() |
W. S. Begolka, C. L. Vanderlugt, S. M. Rahbe, and S. D. Miller Differential Expression of Inflammatory Cytokines Parallels Progression of Central Nervous System Pathology in Two Clinically Distinct Models of Multiple Sclerosis J. Immunol., October 15, 1998; 161(8): 4437 - 4446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Yauch, J. P. Palma, H. Yahikozawa, C.-S. Koh, and B. S. Kim Role of Individual T-Cell Epitopes of Theiler's Virus in the Pathogenesis of Demyelination Correlates with the Ability To Induce a Th1 Response J. Virol., July 1, 1998; 72(7): 6169 - 6174. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Kim, R. L. Yauch, Y. Y. Bahk, J.-A. Kang, M. C. Dal Canto, and C. K. Hall A Spontaneous Low-Pathogenic Variant of Theiler's Virus Contains an Amino Acid Substitution within the Predominant VP1233-250 T-Cell Epitope J. Virol., February 1, 1998; 72(2): 1020 - 1027. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |